Mobilan (M-VM3)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mobilan (M-VM3), covering 2017-09-20 to 2017-09-20. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer [Phase 1, Phase 2]